A single center experience with publicly funded clinical exome sequencing for neurodevelopmental disorders or multiple congenital anomalies
Exome sequencing (ES) is an important diagnostic tool for individuals with neurodevelopmental disorders (NDD) and/or multiple congenital anomalies (MCA). However, the cost of ES limits the test's accessibility for many patients. We evaluated the yield of publicly funded clinical ES, performed a...
Saved in:
| Published in | Scientific reports Vol. 11; no. 1; pp. 19099 - 8 |
|---|---|
| Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
London
Nature Publishing Group UK
27.09.2021
Nature Publishing Group Nature Portfolio |
| Subjects | |
| Online Access | Get full text |
| ISSN | 2045-2322 2045-2322 |
| DOI | 10.1038/s41598-021-98646-w |
Cover
| Abstract | Exome sequencing (ES) is an important diagnostic tool for individuals with neurodevelopmental disorders (NDD) and/or multiple congenital anomalies (MCA). However, the cost of ES limits the test's accessibility for many patients. We evaluated the yield of publicly funded clinical ES, performed at a tertiary center in Israel, over a 3-year period (2018–2020). Probands presented with (1) moderate-to-profound global developmental delay (GDD)/intellectual disability (ID); or (2) mild GDD/ID with epilepsy or congenital anomaly; and/or (3) MCA. Subjects with normal chromosomal microarray analysis who met inclusion criteria were included, totaling 280 consecutive cases. Trio ES (proband and parents) was the default option. In 252 cases (90.0%), indication of NDD was noted. Most probands were males (62.9%), and their mean age at ES submission was 9.3 years (range 1 month to 51 years). Molecular diagnosis was reached in 109 probands (38.9%), mainly due to de novo variants (91/109, 83.5%). Disease-causing variants were identified in 92 genes, 15 of which were implicated in more than a single case. Male sex, families with multiple-affected members and premature birth were significantly associated with lower ES yield (
p
< 0.05). Other factors, including MCA and coexistence of epilepsy, autism spectrum disorder, microcephaly or abnormal brain magnetic resonance imaging findings, were not associated with the yield. To conclude, our findings support the utility of clinical ES in a real-world setting, as part of a publicly funded genetic workup for individuals with GDD/ID and/or MCA. |
|---|---|
| AbstractList | Abstract Exome sequencing (ES) is an important diagnostic tool for individuals with neurodevelopmental disorders (NDD) and/or multiple congenital anomalies (MCA). However, the cost of ES limits the test's accessibility for many patients. We evaluated the yield of publicly funded clinical ES, performed at a tertiary center in Israel, over a 3-year period (2018–2020). Probands presented with (1) moderate-to-profound global developmental delay (GDD)/intellectual disability (ID); or (2) mild GDD/ID with epilepsy or congenital anomaly; and/or (3) MCA. Subjects with normal chromosomal microarray analysis who met inclusion criteria were included, totaling 280 consecutive cases. Trio ES (proband and parents) was the default option. In 252 cases (90.0%), indication of NDD was noted. Most probands were males (62.9%), and their mean age at ES submission was 9.3 years (range 1 month to 51 years). Molecular diagnosis was reached in 109 probands (38.9%), mainly due to de novo variants (91/109, 83.5%). Disease-causing variants were identified in 92 genes, 15 of which were implicated in more than a single case. Male sex, families with multiple-affected members and premature birth were significantly associated with lower ES yield (p < 0.05). Other factors, including MCA and coexistence of epilepsy, autism spectrum disorder, microcephaly or abnormal brain magnetic resonance imaging findings, were not associated with the yield. To conclude, our findings support the utility of clinical ES in a real-world setting, as part of a publicly funded genetic workup for individuals with GDD/ID and/or MCA. Exome sequencing (ES) is an important diagnostic tool for individuals with neurodevelopmental disorders (NDD) and/or multiple congenital anomalies (MCA). However, the cost of ES limits the test's accessibility for many patients. We evaluated the yield of publicly funded clinical ES, performed at a tertiary center in Israel, over a 3-year period (2018–2020). Probands presented with (1) moderate-to-profound global developmental delay (GDD)/intellectual disability (ID); or (2) mild GDD/ID with epilepsy or congenital anomaly; and/or (3) MCA. Subjects with normal chromosomal microarray analysis who met inclusion criteria were included, totaling 280 consecutive cases. Trio ES (proband and parents) was the default option. In 252 cases (90.0%), indication of NDD was noted. Most probands were males (62.9%), and their mean age at ES submission was 9.3 years (range 1 month to 51 years). Molecular diagnosis was reached in 109 probands (38.9%), mainly due to de novo variants (91/109, 83.5%). Disease-causing variants were identified in 92 genes, 15 of which were implicated in more than a single case. Male sex, families with multiple-affected members and premature birth were significantly associated with lower ES yield (p < 0.05). Other factors, including MCA and coexistence of epilepsy, autism spectrum disorder, microcephaly or abnormal brain magnetic resonance imaging findings, were not associated with the yield. To conclude, our findings support the utility of clinical ES in a real-world setting, as part of a publicly funded genetic workup for individuals with GDD/ID and/or MCA. Exome sequencing (ES) is an important diagnostic tool for individuals with neurodevelopmental disorders (NDD) and/or multiple congenital anomalies (MCA). However, the cost of ES limits the test's accessibility for many patients. We evaluated the yield of publicly funded clinical ES, performed at a tertiary center in Israel, over a 3-year period (2018–2020). Probands presented with (1) moderate-to-profound global developmental delay (GDD)/intellectual disability (ID); or (2) mild GDD/ID with epilepsy or congenital anomaly; and/or (3) MCA. Subjects with normal chromosomal microarray analysis who met inclusion criteria were included, totaling 280 consecutive cases. Trio ES (proband and parents) was the default option. In 252 cases (90.0%), indication of NDD was noted. Most probands were males (62.9%), and their mean age at ES submission was 9.3 years (range 1 month to 51 years). Molecular diagnosis was reached in 109 probands (38.9%), mainly due to de novo variants (91/109, 83.5%). Disease-causing variants were identified in 92 genes, 15 of which were implicated in more than a single case. Male sex, families with multiple-affected members and premature birth were significantly associated with lower ES yield ( p < 0.05). Other factors, including MCA and coexistence of epilepsy, autism spectrum disorder, microcephaly or abnormal brain magnetic resonance imaging findings, were not associated with the yield. To conclude, our findings support the utility of clinical ES in a real-world setting, as part of a publicly funded genetic workup for individuals with GDD/ID and/or MCA. Exome sequencing (ES) is an important diagnostic tool for individuals with neurodevelopmental disorders (NDD) and/or multiple congenital anomalies (MCA). However, the cost of ES limits the test's accessibility for many patients. We evaluated the yield of publicly funded clinical ES, performed at a tertiary center in Israel, over a 3-year period (2018-2020). Probands presented with (1) moderate-to-profound global developmental delay (GDD)/intellectual disability (ID); or (2) mild GDD/ID with epilepsy or congenital anomaly; and/or (3) MCA. Subjects with normal chromosomal microarray analysis who met inclusion criteria were included, totaling 280 consecutive cases. Trio ES (proband and parents) was the default option. In 252 cases (90.0%), indication of NDD was noted. Most probands were males (62.9%), and their mean age at ES submission was 9.3 years (range 1 month to 51 years). Molecular diagnosis was reached in 109 probands (38.9%), mainly due to de novo variants (91/109, 83.5%). Disease-causing variants were identified in 92 genes, 15 of which were implicated in more than a single case. Male sex, families with multiple-affected members and premature birth were significantly associated with lower ES yield (p < 0.05). Other factors, including MCA and coexistence of epilepsy, autism spectrum disorder, microcephaly or abnormal brain magnetic resonance imaging findings, were not associated with the yield. To conclude, our findings support the utility of clinical ES in a real-world setting, as part of a publicly funded genetic workup for individuals with GDD/ID and/or MCA. Exome sequencing (ES) is an important diagnostic tool for individuals with neurodevelopmental disorders (NDD) and/or multiple congenital anomalies (MCA). However, the cost of ES limits the test's accessibility for many patients. We evaluated the yield of publicly funded clinical ES, performed at a tertiary center in Israel, over a 3-year period (2018-2020). Probands presented with (1) moderate-to-profound global developmental delay (GDD)/intellectual disability (ID); or (2) mild GDD/ID with epilepsy or congenital anomaly; and/or (3) MCA. Subjects with normal chromosomal microarray analysis who met inclusion criteria were included, totaling 280 consecutive cases. Trio ES (proband and parents) was the default option. In 252 cases (90.0%), indication of NDD was noted. Most probands were males (62.9%), and their mean age at ES submission was 9.3 years (range 1 month to 51 years). Molecular diagnosis was reached in 109 probands (38.9%), mainly due to de novo variants (91/109, 83.5%). Disease-causing variants were identified in 92 genes, 15 of which were implicated in more than a single case. Male sex, families with multiple-affected members and premature birth were significantly associated with lower ES yield (p < 0.05). Other factors, including MCA and coexistence of epilepsy, autism spectrum disorder, microcephaly or abnormal brain magnetic resonance imaging findings, were not associated with the yield. To conclude, our findings support the utility of clinical ES in a real-world setting, as part of a publicly funded genetic workup for individuals with GDD/ID and/or MCA.Exome sequencing (ES) is an important diagnostic tool for individuals with neurodevelopmental disorders (NDD) and/or multiple congenital anomalies (MCA). However, the cost of ES limits the test's accessibility for many patients. We evaluated the yield of publicly funded clinical ES, performed at a tertiary center in Israel, over a 3-year period (2018-2020). Probands presented with (1) moderate-to-profound global developmental delay (GDD)/intellectual disability (ID); or (2) mild GDD/ID with epilepsy or congenital anomaly; and/or (3) MCA. Subjects with normal chromosomal microarray analysis who met inclusion criteria were included, totaling 280 consecutive cases. Trio ES (proband and parents) was the default option. In 252 cases (90.0%), indication of NDD was noted. Most probands were males (62.9%), and their mean age at ES submission was 9.3 years (range 1 month to 51 years). Molecular diagnosis was reached in 109 probands (38.9%), mainly due to de novo variants (91/109, 83.5%). Disease-causing variants were identified in 92 genes, 15 of which were implicated in more than a single case. Male sex, families with multiple-affected members and premature birth were significantly associated with lower ES yield (p < 0.05). Other factors, including MCA and coexistence of epilepsy, autism spectrum disorder, microcephaly or abnormal brain magnetic resonance imaging findings, were not associated with the yield. To conclude, our findings support the utility of clinical ES in a real-world setting, as part of a publicly funded genetic workup for individuals with GDD/ID and/or MCA. |
| ArticleNumber | 19099 |
| Author | Tzadok, Michal Mor, Nofar Berkenstadt, Michal Pras, Elon Segev, Meirav Pode-Shakked, Ben Regev, Miriam Barel, Ortal Finezilber, Yael Greenbaum, Lior Singer, Amihood Grinshpun-Cohen, Julia Chorin, Odelia Heimer, Gali Nayshool, Omri Marek-Yagel, Dina Zohar-Dayan, Efrat Yonath, Hagith Javasky, Elisheva Shimshoviz, Noam Gal, Moran Gazit, Yael Kol, Nitzan Nissenkorn, Andreea Poran, Hana Dominissini, Dan Raas-Rothschild, Annick Gabis, Lidia V. Einy, Reviva Eliyahu, Aviva Bar-Yosef, Omer Reznik-Wolf, Haike Ben-Zeev, Bruria Bar-Joseph, Ifat Shohat, Mordechai Rechavi, Gideon |
| Author_xml | – sequence: 1 givenname: Ben surname: Pode-Shakked fullname: Pode-Shakked, Ben email: Ben.PodeShakhed@sheba.health.gov.il organization: The Danek Gertner Institute of Human Genetics, Sheba Medical Center, The Institute for Rare Diseases, Edmond and Lily Safra Children’s Hospital, Sheba Medical Center, Talpiot Medical Leadership Program, Sheba Medical Center, Sackler Faculty of Medicine, Tel Aviv University – sequence: 2 givenname: Ortal surname: Barel fullname: Barel, Ortal organization: The Genomics Unit, Sheba Cancer Research Center, Sheba Medical Center, The Wohl Institute for Translational Medicine, and the Sheba Cancer Research Center, Sheba Medical Center – sequence: 3 givenname: Amihood surname: Singer fullname: Singer, Amihood organization: Community Genetics, Public Health Services, Ministry of Health – sequence: 4 givenname: Miriam surname: Regev fullname: Regev, Miriam organization: The Danek Gertner Institute of Human Genetics, Sheba Medical Center, Sackler Faculty of Medicine, Tel Aviv University – sequence: 5 givenname: Hana surname: Poran fullname: Poran, Hana organization: The Danek Gertner Institute of Human Genetics, Sheba Medical Center, Sackler Faculty of Medicine, Tel Aviv University – sequence: 6 givenname: Aviva surname: Eliyahu fullname: Eliyahu, Aviva organization: The Danek Gertner Institute of Human Genetics, Sheba Medical Center, Sackler Faculty of Medicine, Tel Aviv University – sequence: 7 givenname: Yael surname: Finezilber fullname: Finezilber, Yael organization: The Danek Gertner Institute of Human Genetics, Sheba Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Internal Medicine A, Sheba Medical Center – sequence: 8 givenname: Meirav surname: Segev fullname: Segev, Meirav organization: The Danek Gertner Institute of Human Genetics, Sheba Medical Center, Sackler Faculty of Medicine, Tel Aviv University – sequence: 9 givenname: Michal surname: Berkenstadt fullname: Berkenstadt, Michal organization: The Danek Gertner Institute of Human Genetics, Sheba Medical Center, Sackler Faculty of Medicine, Tel Aviv University – sequence: 10 givenname: Hagith surname: Yonath fullname: Yonath, Hagith organization: The Danek Gertner Institute of Human Genetics, Sheba Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Internal Medicine A, Sheba Medical Center – sequence: 11 givenname: Haike surname: Reznik-Wolf fullname: Reznik-Wolf, Haike organization: The Danek Gertner Institute of Human Genetics, Sheba Medical Center, Sackler Faculty of Medicine, Tel Aviv University – sequence: 12 givenname: Yael surname: Gazit fullname: Gazit, Yael organization: The Danek Gertner Institute of Human Genetics, Sheba Medical Center, Sackler Faculty of Medicine, Tel Aviv University – sequence: 13 givenname: Odelia surname: Chorin fullname: Chorin, Odelia organization: The Danek Gertner Institute of Human Genetics, Sheba Medical Center, The Institute for Rare Diseases, Edmond and Lily Safra Children’s Hospital, Sheba Medical Center, Sackler Faculty of Medicine, Tel Aviv University – sequence: 14 givenname: Gali surname: Heimer fullname: Heimer, Gali organization: Talpiot Medical Leadership Program, Sheba Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Pediatric Neurology Unit, Edmond and Lily Safra Children’s Hospital, Sheba Medical Center – sequence: 15 givenname: Lidia V. surname: Gabis fullname: Gabis, Lidia V. organization: Sackler Faculty of Medicine, Tel Aviv University – sequence: 16 givenname: Michal surname: Tzadok fullname: Tzadok, Michal organization: Sackler Faculty of Medicine, Tel Aviv University, Pediatric Neurology Unit, Edmond and Lily Safra Children’s Hospital, Sheba Medical Center – sequence: 17 givenname: Andreea surname: Nissenkorn fullname: Nissenkorn, Andreea organization: Sackler Faculty of Medicine, Tel Aviv University, Pediatric Neurology Unit, Edmond and Lily Safra Children’s Hospital, Sheba Medical Center, Pediatric Neurology Unit, Edith Wolfson Medical Center – sequence: 18 givenname: Omer surname: Bar-Yosef fullname: Bar-Yosef, Omer organization: Talpiot Medical Leadership Program, Sheba Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Pediatric Neurology Unit, Edmond and Lily Safra Children’s Hospital, Sheba Medical Center – sequence: 19 givenname: Efrat surname: Zohar-Dayan fullname: Zohar-Dayan, Efrat organization: Sackler Faculty of Medicine, Tel Aviv University, Pediatric Neurology Unit, Edmond and Lily Safra Children’s Hospital, Sheba Medical Center – sequence: 20 givenname: Bruria surname: Ben-Zeev fullname: Ben-Zeev, Bruria organization: Sackler Faculty of Medicine, Tel Aviv University, Pediatric Neurology Unit, Edmond and Lily Safra Children’s Hospital, Sheba Medical Center – sequence: 21 givenname: Nofar surname: Mor fullname: Mor, Nofar organization: The Genomics Unit, Sheba Cancer Research Center, Sheba Medical Center – sequence: 22 givenname: Nitzan surname: Kol fullname: Kol, Nitzan organization: The Genomics Unit, Sheba Cancer Research Center, Sheba Medical Center – sequence: 23 givenname: Omri surname: Nayshool fullname: Nayshool, Omri organization: The Genomics Unit, Sheba Cancer Research Center, Sheba Medical Center – sequence: 24 givenname: Noam surname: Shimshoviz fullname: Shimshoviz, Noam organization: The Genomics Unit, Sheba Cancer Research Center, Sheba Medical Center – sequence: 25 givenname: Ifat surname: Bar-Joseph fullname: Bar-Joseph, Ifat organization: The Genomics Unit, Sheba Cancer Research Center, Sheba Medical Center – sequence: 26 givenname: Dina surname: Marek-Yagel fullname: Marek-Yagel, Dina organization: The Genomics Unit, Sheba Cancer Research Center, Sheba Medical Center – sequence: 27 givenname: Elisheva surname: Javasky fullname: Javasky, Elisheva organization: The Genomics Unit, Sheba Cancer Research Center, Sheba Medical Center – sequence: 28 givenname: Reviva surname: Einy fullname: Einy, Reviva organization: The Institute for Rare Diseases, Edmond and Lily Safra Children’s Hospital, Sheba Medical Center – sequence: 29 givenname: Moran surname: Gal fullname: Gal, Moran organization: The Institute for Rare Diseases, Edmond and Lily Safra Children’s Hospital, Sheba Medical Center – sequence: 30 givenname: Julia surname: Grinshpun-Cohen fullname: Grinshpun-Cohen, Julia organization: Community Genetics, Public Health Services, Ministry of Health – sequence: 31 givenname: Mordechai surname: Shohat fullname: Shohat, Mordechai organization: Sackler Faculty of Medicine, Tel Aviv University, The Genomics Unit, Sheba Cancer Research Center, Sheba Medical Center – sequence: 32 givenname: Dan surname: Dominissini fullname: Dominissini, Dan organization: Sackler Faculty of Medicine, Tel Aviv University, The Genomics Unit, Sheba Cancer Research Center, Sheba Medical Center, The Wohl Institute for Translational Medicine, and the Sheba Cancer Research Center, Sheba Medical Center – sequence: 33 givenname: Annick surname: Raas-Rothschild fullname: Raas-Rothschild, Annick organization: The Institute for Rare Diseases, Edmond and Lily Safra Children’s Hospital, Sheba Medical Center, Sackler Faculty of Medicine, Tel Aviv University – sequence: 34 givenname: Gideon surname: Rechavi fullname: Rechavi, Gideon organization: Sackler Faculty of Medicine, Tel Aviv University, The Genomics Unit, Sheba Cancer Research Center, Sheba Medical Center, The Wohl Institute for Translational Medicine, and the Sheba Cancer Research Center, Sheba Medical Center – sequence: 35 givenname: Elon surname: Pras fullname: Pras, Elon organization: The Danek Gertner Institute of Human Genetics, Sheba Medical Center, Sackler Faculty of Medicine, Tel Aviv University – sequence: 36 givenname: Lior surname: Greenbaum fullname: Greenbaum, Lior organization: The Danek Gertner Institute of Human Genetics, Sheba Medical Center, Sackler Faculty of Medicine, Tel Aviv University, The Joseph Sagol Neuroscience Center, Sheba Medical Center |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34580403$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9ks1u3SAQha0qVZOmeYEuKkvddOMWDNh4UymK-hMpUjftGmEY33CF4Rbs3OQZ-tIdx2maZBE2IPjOmWFmXhcHIQYoireUfKSEyU-ZU9HJitS06mTDm2r_ojiqCRdVzer64MH5sDjJeUtwibrjtHtVHDIuJOGEHRV_TsvswsZDaSBMkEq43kFyEAyUezddlru59874m3KYgwVbGu-CM9ojGEcoM_yeEUaLcoipDDCnaOEKfNyNaIicdTkmCymX-D7OfnK7JVoMGwhuAXSIo_YO8pvi5aB9hpO7_bj49fXLz7Pv1cWPb-dnpxeVEZxMlTVGmpqKVvQNpSA6a1jdEin6TjMJRIhBWETk0DBqTMe0HSiVQ8fbhhPes-PifPW1UW_VLrlRpxsVtVO3FzFtlE4TfhoUtIz1PfpIY7npjbaG2FZqSvtWM2PR6_PqhXUawS5FTNo_Mn38Etyl2sQrJTGbhnE0-HBnkCKWMk9qdNmA9zpAnLOqRdty0TZCIvr-CbqNcwpYqoVqWtY2ZKHePczoPpV_PUegXgGTYs4JhnuEErXMllpnS-FsqdvZUnsUyScig82bXFx-5fzzUrZKM8bBrqf_aT-j-gvYnehO |
| CitedBy_id | crossref_primary_10_3389_fgene_2022_991721 crossref_primary_10_1038_s41525_023_00353_0 crossref_primary_10_1002_humu_24466 crossref_primary_10_3389_fped_2022_844845 crossref_primary_10_1002_ajmg_a_62667 crossref_primary_10_1016_j_ekir_2023_07_019 crossref_primary_10_1136_bcr_2022_251871 crossref_primary_10_1186_s40246_023_00485_5 crossref_primary_10_3389_fgene_2022_1018062 crossref_primary_10_1016_j_jns_2024_123074 crossref_primary_10_1016_j_gimo_2023_100828 crossref_primary_10_1038_s41598_024_79431_x crossref_primary_10_1186_s12889_023_16489_8 crossref_primary_10_1016_j_gim_2023_100896 crossref_primary_10_1097_MD_0000000000040923 crossref_primary_10_1186_s13023_025_03598_3 |
| Cites_doi | 10.1111/cge.13102 10.1002/ajmg.a.61483 10.1038/ng.806 10.1016/S1474-4422(11)70196-X 10.1038/tp.2016.294 10.1038/s41467-019-11039-6 10.1038/gim.2015.30 10.1001/jama.2014.14604 10.1038/nature21062 10.1038/ncomms10486 10.1016/j.ajhg.2020.11.015 10.1016/S0140-6736(19)31274-7 10.1002/humu.22844 10.1016/S0140-6736(14)61705-0 10.1111/cge.13946 10.1056/NEJMoa1306555 10.1016/j.ajhg.2015.07.004 10.1016/j.ajhg.2017.09.008 10.1038/gim.2015.148 10.1093/brain/awaa051 10.1093/nar/gkr1257 10.1007/s10803-006-0280-1 10.1038/nature14135 10.1016/j.ajhg.2018.12.002 10.1146/annurev-genet-112618-043617 10.1111/cge.13823 10.1002/ajmg.a.62026 10.1371/journal.pgen.1004772 10.1016/j.tig.2019.08.005 10.1038/nature12439 10.1038/s41586-020-2832-5 10.1159/000450991 10.1038/s41588-018-0143-7 10.1038/s41436-019-0554-6 10.1007/s10803-012-1627-4 10.1111/cge.14006 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2021 2021. The Author(s). The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: The Author(s) 2021 – notice: 2021. The Author(s). – notice: The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88A 88E 88I 8FE 8FH 8FI 8FJ 8FK ABUWG AEUYN AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M2P M7P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS Q9U 7X8 5PM DOA |
| DOI | 10.1038/s41598-021-98646-w |
| DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Complete (ProQuest Database) ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Medical Database (Alumni Edition) Science Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest One Sustainability (subscription) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection Medical Database Science Database (subscription) Biological Science Database Proquest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals (WRLC) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central China ProQuest Biology Journals (Alumni Edition) ProQuest Central ProQuest One Applied & Life Sciences ProQuest One Sustainability ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Publicly Available Content Database CrossRef MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 5 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 2045-2322 |
| EndPage | 8 |
| ExternalDocumentID | oai_doaj_org_article_e733bb6318cd4cbcadc0d78a11b7a3cd PMC8476634 34580403 10_1038_s41598_021_98646_w |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GeographicLocations | Israel |
| GeographicLocations_xml | – name: Israel |
| GroupedDBID | 0R~ 3V. 4.4 53G 5VS 7X7 88A 88E 88I 8FE 8FH 8FI 8FJ AAFWJ AAJSJ AAKDD ABDBF ABUWG ACGFS ACSMW ACUHS ADBBV ADRAZ AENEX AEUYN AFKRA AJTQC ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI C6C CCPQU DIK DWQXO EBD EBLON EBS ESX FYUFA GNUQQ GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE KQ8 LK8 M0L M1P M2P M48 M7P M~E NAO OK1 PIMPY PQQKQ PROAC PSQYO RNT RNTTT RPM SNYQT UKHRP AASML AAYXX AFPKN CITATION PHGZM PHGZT CGR CUY CVF ECM EIF NPM 7XB 8FK AARCD K9. PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS Q9U 7X8 PUEGO 5PM |
| ID | FETCH-LOGICAL-c540t-dcc8c21575b611e59dc327085b9a38e055f5dc8c8f631cc93adf118f9476404b3 |
| IEDL.DBID | M48 |
| ISSN | 2045-2322 |
| IngestDate | Wed Aug 27 01:28:24 EDT 2025 Thu Aug 21 18:21:47 EDT 2025 Fri Sep 05 10:24:00 EDT 2025 Wed Aug 13 06:12:23 EDT 2025 Thu Jan 02 22:55:34 EST 2025 Tue Jul 01 03:49:22 EDT 2025 Thu Apr 24 23:11:51 EDT 2025 Fri Feb 21 02:39:37 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Language | English |
| License | 2021. The Author(s). Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c540t-dcc8c21575b611e59dc327085b9a38e055f5dc8c8f631cc93adf118f9476404b3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| OpenAccessLink | https://www.nature.com/articles/s41598-021-98646-w |
| PMID | 34580403 |
| PQID | 2576737608 |
| PQPubID | 2041939 |
| PageCount | 8 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_e733bb6318cd4cbcadc0d78a11b7a3cd pubmedcentral_primary_oai_pubmedcentral_nih_gov_8476634 proquest_miscellaneous_2577457658 proquest_journals_2576737608 pubmed_primary_34580403 crossref_primary_10_1038_s41598_021_98646_w crossref_citationtrail_10_1038_s41598_021_98646_w springer_journals_10_1038_s41598_021_98646_w |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2021-09-27 |
| PublicationDateYYYYMMDD | 2021-09-27 |
| PublicationDate_xml | – month: 09 year: 2021 text: 2021-09-27 day: 27 |
| PublicationDecade | 2020 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | Scientific reports |
| PublicationTitleAbbrev | Sci Rep |
| PublicationTitleAlternate | Sci Rep |
| PublicationYear | 2021 |
| Publisher | Nature Publishing Group UK Nature Publishing Group Nature Portfolio |
| Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group – name: Nature Portfolio |
| References | Sobreira, Schiettecatte, Valle, Hamosh (CR41) 2015; 36 Richards (CR19) 2015; 17 Chérot (CR12) 2018; 93 Depristo (CR17) 2011; 43 CR16 Heyne (CR35) 2018; 50 Wong (CR31) 2016; 7 Retterer (CR8) 2016; 18 Ku, Cooper, Patrinos (CR4) 2016; 19 Wechsler (CR14) 2002 Wechsler (CR15) 2014 Gotham (CR22) 2007; 37 Lin (CR40) 2021; 108 (CR1) 2017; 542 Kanani (CR37) 2020; 182 Janecka (CR28) 2017; 7 Stern (CR38) 2021; 185 Lee (CR7) 2014; 312 Kaplanis (CR24) 2020; 586 Aitken, De Iuliis, Nixon (CR30) 2020; 54 Strivastava (CR9) 2019; 21 Rutter (CR20) 2003 Reynhout (CR39) 2019; 104 Grant (CR25) 2021 Hamdan (CR26) 2014; 10 Li, Gui, Kwan, Bao, Sham (CR18) 2012; 40 Snijders Blok (CR36) 2015; 97 Singleton (CR3) 2011; 10 Wright (CR11) 2015; 385 Minardi (CR33) 2020; 98 Mullen (CR13) 1995 Hamdan (CR27) 2017; 101 Brunet (CR5) 2021; 100 Wise, Manolio, Menash, Peterson, Roden (CR10) 2019; 394 (CR23) 2015; 519 Taylor (CR29) 2019; 10 Duku (CR21) 2013; 43 Yang (CR6) 2013; 369 (CR34) 2013; 501 López-Rivera (CR2) 2020; 143 Goldman, Veltman, Gilissen (CR32) 2019; 35 T Stern (98646_CR38) 2021; 185 MX Li (98646_CR18) 2012; 40 F Kanani (98646_CR37) 2020; 182 K Retterer (98646_CR8) 2016; 18 CF Wright (98646_CR11) 2015; 385 HO Heyne (98646_CR35) 2018; 50 L Snijders Blok (98646_CR36) 2015; 97 98646_CR16 YC Lin (98646_CR40) 2021; 108 JL Taylor (98646_CR29) 2019; 10 JA López-Rivera (98646_CR2) 2020; 143 Deciphering Developmental Disorders Study (98646_CR1) 2017; 542 D Wechsler (98646_CR15) 2014 JM Goldman (98646_CR32) 2019; 35 M Depristo (98646_CR17) 2011; 43 Epi4K Consortium (98646_CR34) 2013; 501 FF Hamdan (98646_CR26) 2014; 10 K Gotham (98646_CR22) 2007; 37 AB Singleton (98646_CR3) 2011; 10 D Wechsler (98646_CR14) 2002 M Rutter (98646_CR20) 2003 WSW Wong (98646_CR31) 2016; 7 AL Wise (98646_CR10) 2019; 394 R Minardi (98646_CR33) 2020; 98 T Brunet (98646_CR5) 2021; 100 P Grant (98646_CR25) 2021 J Kaplanis (98646_CR24) 2020; 586 E Chérot (98646_CR12) 2018; 93 S Richards (98646_CR19) 2015; 17 EM Mullen (98646_CR13) 1995 Deciphering Developmental Disorders Study (98646_CR23) 2015; 519 RJ Aitken (98646_CR30) 2020; 54 CS Ku (98646_CR4) 2016; 19 FF Hamdan (98646_CR27) 2017; 101 E Duku (98646_CR21) 2013; 43 S Reynhout (98646_CR39) 2019; 104 Y Yang (98646_CR6) 2013; 369 S Strivastava (98646_CR9) 2019; 21 H Lee (98646_CR7) 2014; 312 N Sobreira (98646_CR41) 2015; 36 M Janecka (98646_CR28) 2017; 7 |
| References_xml | – volume: 93 start-page: 567 issue: 3 year: 2018 end-page: 576 ident: CR12 article-title: Using medical exome sequencing to identify the causes of neurodevelopmental disorders: Experience of 2 clinical units and 216 patients publication-title: Clin. Genet. doi: 10.1111/cge.13102 – year: 2002 ident: CR14 publication-title: WPPSI-III: Technical and Interpretative Manual – year: 2014 ident: CR15 publication-title: Wechsler Intelligence Scale for Children-Fifth Edition (WISC-V) – volume: 182 start-page: 713 issue: 4 year: 2020 end-page: 720 ident: CR37 article-title: Expanding the genotype-phenotype correlation of de novo heterozygous missense variants in YWHAG as a cause of developmental and epileptic encephalopathy publication-title: Am. J. Med. Genet. A doi: 10.1002/ajmg.a.61483 – volume: 43 start-page: 491 issue: 5 year: 2011 end-page: 498 ident: CR17 article-title: A framework for variation discovery and genotyping using next-generation DNA sequencing data publication-title: Nat. Genet. doi: 10.1038/ng.806 – volume: 10 start-page: 942 issue: 10 year: 2011 end-page: 946 ident: CR3 article-title: Exome sequencing: A transformative technology publication-title: Lancet Neurol. doi: 10.1016/S1474-4422(11)70196-X – ident: CR16 – volume: 7 start-page: e1019 issue: 1 year: 2017 ident: CR28 article-title: Advanced paternal age effects in neurodevelopmental disorders—Review of potential underlying mechanisms publication-title: Transl. Psychiatry doi: 10.1038/tp.2016.294 – volume: 10 start-page: 3043 issue: 1 year: 2019 ident: CR29 article-title: Paternal-age-related de novo mutations and risk for five disorders publication-title: Nat. Commun. doi: 10.1038/s41467-019-11039-6 – volume: 17 start-page: 405 issue: 5 year: 2015 end-page: 424 ident: CR19 article-title: Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology publication-title: Genet. Med. doi: 10.1038/gim.2015.30 – volume: 312 start-page: 1880 issue: 18 year: 2014 end-page: 1887 ident: CR7 article-title: Clinical exome sequencing for genetic identification of rare Mendelian disorders publication-title: JAMA doi: 10.1001/jama.2014.14604 – volume: 542 start-page: 433 issue: 7642 year: 2017 end-page: 438 ident: CR1 article-title: Prevalence and architecture of de novo mutations in developmental disorders publication-title: Nature doi: 10.1038/nature21062 – volume: 7 start-page: 10486 year: 2016 ident: CR31 article-title: New observations on maternal age effect on germline de novo mutations publication-title: Nat. Commun. doi: 10.1038/ncomms10486 – year: 2003 ident: CR20 publication-title: The Social Communication Questionnaire—Manual – volume: 108 start-page: 115 issue: 1 year: 2021 end-page: 133 ident: CR40 article-title: SCUBE3 loss-of-function causes a recognizable recessive developmental disorder due to defective bone morphogenetic protein signaling publication-title: Am. J. Hum. Genet. doi: 10.1016/j.ajhg.2020.11.015 – volume: 394 start-page: 533 issue: 10197 year: 2019 end-page: 540 ident: CR10 article-title: Genomic medicine for undiagnosed diseases publication-title: Lancet doi: 10.1016/S0140-6736(19)31274-7 – volume: 36 start-page: 928 issue: 10 year: 2015 end-page: 930 ident: CR41 article-title: GeneMatcher: a matching tool for connecting investigators with an interest in the same gene publication-title: Hum. Mutat. doi: 10.1002/humu.22844 – volume: 385 start-page: 1305 issue: 9975 year: 2015 end-page: 1314 ident: CR11 article-title: Genetic diagnosis of developmental disorders in the DDD study: A scalable analysis of genome-wide research data publication-title: Lancet doi: 10.1016/S0140-6736(14)61705-0 – volume: 100 start-page: 14 issue: 1 year: 2021 end-page: 28 ident: CR5 article-title: De novo variants in neurodevelopmental disorders—Experiences from a tertiary care center publication-title: Clin. Genet. doi: 10.1111/cge.13946 – volume: 369 start-page: 1502 year: 2013 end-page: 1511 ident: CR6 article-title: Clinical whole-exome sequencing for the diagnosis of Mendelian disorders publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1306555 – volume: 97 start-page: 343 issue: 2 year: 2015 end-page: 352 ident: CR36 article-title: Mutations in DDX3X are a common cause of unexplained intellectual disability with gender-specific effects on Wnt signaling publication-title: Am. J. Hum. Genet. doi: 10.1016/j.ajhg.2015.07.004 – volume: 101 start-page: 664 issue: 5 year: 2017 end-page: 685 ident: CR27 article-title: High rate of recurrent de novo mutations in developmental and epileptic encephalopathies publication-title: Am. J. Hum. Genet. doi: 10.1016/j.ajhg.2017.09.008 – volume: 18 start-page: 696 issue: 7 year: 2016 end-page: 704 ident: CR8 article-title: Clinical application of whole-exome sequencing across clinical indications publication-title: Genet. Med. doi: 10.1038/gim.2015.148 – volume: 143 start-page: 1099 issue: 4 year: 2020 end-page: 1105 ident: CR2 article-title: A catalogue of new incidence estimates of monogenic neurodevelopmental disorders caused by de novo variants publication-title: Brain doi: 10.1093/brain/awaa051 – volume: 40 start-page: e53 issue: 7 year: 2012 ident: CR18 article-title: A comprehensive framework for prioritizing variants in exome sequencing studies of Mendelian disease publication-title: Nucleic Acids Res. doi: 10.1093/nar/gkr1257 – volume: 37 start-page: 613 issue: 4 year: 2007 end-page: 627 ident: CR22 article-title: The Autism Diagnostic Observation Schedule: Revised algorithms for improved diagnostic validity publication-title: J. Autism Dev. Disord. doi: 10.1007/s10803-006-0280-1 – volume: 519 start-page: 223 issue: 7542 year: 2015 end-page: 228 ident: CR23 article-title: Large-scale discovery of novel genetic causes of developmental disorders publication-title: Nature doi: 10.1038/nature14135 – volume: 104 start-page: 139 issue: 1 year: 2019 end-page: 156 ident: CR39 article-title: De novo mutations affecting the catalytic Cα subunit of PPSA, PPP2CA, cause syndromic intellectual disability resembling other PP2A-related neurodevelopmental disorders publication-title: Am. J. Hum. Genet. doi: 10.1016/j.ajhg.2018.12.002 – volume: 54 start-page: 1 year: 2020 end-page: 24 ident: CR30 article-title: The sins of our forefathers: Paternal impacts on de novo mutation rate and development publication-title: Annu. Rev. Genet. doi: 10.1146/annurev-genet-112618-043617 – volume: 98 start-page: 477 issue: 5 year: 2020 end-page: 485 ident: CR33 article-title: Whole-exome sequencing in adult patients with developmental and epileptic encephalopathy: It is never too late publication-title: Clin. Genet. doi: 10.1111/cge.13823 – volume: 185 start-page: 901 issue: 3 year: 2021 end-page: 908 ident: CR38 article-title: Epilepsy and electroencephalogram evolution in YWHAG gene mutation: A new phenotype and review of the literature publication-title: Am. J. Med. Genet. A doi: 10.1002/ajmg.a.62026 – volume: 10 start-page: e1004772 issue: 10 year: 2014 ident: CR26 article-title: De novo mutations in moderate or severe intellectual disability publication-title: PLoS Genet. doi: 10.1371/journal.pgen.1004772 – volume: 35 start-page: 828 issue: 11 year: 2019 end-page: 839 ident: CR32 article-title: novo mutations reflect development and aging of the human germline publication-title: Trends Genet. doi: 10.1016/j.tig.2019.08.005 – volume: 501 start-page: 217 issue: 7466 year: 2013 end-page: 221 ident: CR34 article-title: De novo mutations in epileptic encephalopathies publication-title: Nature doi: 10.1038/nature12439 – volume: 586 start-page: 757 issue: 7831 year: 2020 end-page: 762 ident: CR24 article-title: Evidence for 28 genetic disorders discovered by combining healthcare and research data publication-title: Nature doi: 10.1038/s41586-020-2832-5 – volume: 19 start-page: 315 issue: 6 year: 2016 end-page: 324 ident: CR4 article-title: The rise and rise of exome sequencing publication-title: Public Health Genom. doi: 10.1159/000450991 – year: 1995 ident: CR13 publication-title: Mullen Scales of Early Learning – volume: 50 start-page: 1048 issue: 7 year: 2018 end-page: 1053 ident: CR35 article-title: De novo variants in neurodevelopmental disorders with epilepsy publication-title: Nat. Genet. doi: 10.1038/s41588-018-0143-7 – volume: 21 start-page: 2413 issue: 11 year: 2019 end-page: 2421 ident: CR9 article-title: Meta-analysis and multidisciplinary consensus statement: Exome sequencing is a first-tier clinical diagnostic test for individuals with neurodevelopmental disorders publication-title: Genet. Med. doi: 10.1038/s41436-019-0554-6 – volume: 43 start-page: 860 issue: 4 year: 2013 end-page: 868 ident: CR21 article-title: Investigating the measurement properties of the Social Responsiveness Scale in preschool children with autism spectrum disorders publication-title: J. Autism Dev. Disord. doi: 10.1007/s10803-012-1627-4 – year: 2021 ident: CR25 article-title: Out-of-pocket and private pay in clinical genetic testing: a scoping review publication-title: Clin. Genet. doi: 10.1111/cge.14006 – volume: 312 start-page: 1880 issue: 18 year: 2014 ident: 98646_CR7 publication-title: JAMA doi: 10.1001/jama.2014.14604 – volume: 18 start-page: 696 issue: 7 year: 2016 ident: 98646_CR8 publication-title: Genet. Med. doi: 10.1038/gim.2015.148 – volume: 7 start-page: 10486 year: 2016 ident: 98646_CR31 publication-title: Nat. Commun. doi: 10.1038/ncomms10486 – volume: 182 start-page: 713 issue: 4 year: 2020 ident: 98646_CR37 publication-title: Am. J. Med. Genet. A doi: 10.1002/ajmg.a.61483 – volume: 185 start-page: 901 issue: 3 year: 2021 ident: 98646_CR38 publication-title: Am. J. Med. Genet. A doi: 10.1002/ajmg.a.62026 – volume: 7 start-page: e1019 issue: 1 year: 2017 ident: 98646_CR28 publication-title: Transl. Psychiatry doi: 10.1038/tp.2016.294 – volume: 542 start-page: 433 issue: 7642 year: 2017 ident: 98646_CR1 publication-title: Nature doi: 10.1038/nature21062 – volume: 93 start-page: 567 issue: 3 year: 2018 ident: 98646_CR12 publication-title: Clin. Genet. doi: 10.1111/cge.13102 – volume: 37 start-page: 613 issue: 4 year: 2007 ident: 98646_CR22 publication-title: J. Autism Dev. Disord. doi: 10.1007/s10803-006-0280-1 – volume: 10 start-page: e1004772 issue: 10 year: 2014 ident: 98646_CR26 publication-title: PLoS Genet. doi: 10.1371/journal.pgen.1004772 – volume-title: Mullen Scales of Early Learning year: 1995 ident: 98646_CR13 – volume: 35 start-page: 828 issue: 11 year: 2019 ident: 98646_CR32 publication-title: Trends Genet. doi: 10.1016/j.tig.2019.08.005 – volume: 10 start-page: 942 issue: 10 year: 2011 ident: 98646_CR3 publication-title: Lancet Neurol. doi: 10.1016/S1474-4422(11)70196-X – volume: 17 start-page: 405 issue: 5 year: 2015 ident: 98646_CR19 publication-title: Genet. Med. doi: 10.1038/gim.2015.30 – volume: 104 start-page: 139 issue: 1 year: 2019 ident: 98646_CR39 publication-title: Am. J. Hum. Genet. doi: 10.1016/j.ajhg.2018.12.002 – volume: 21 start-page: 2413 issue: 11 year: 2019 ident: 98646_CR9 publication-title: Genet. Med. doi: 10.1038/s41436-019-0554-6 – volume: 501 start-page: 217 issue: 7466 year: 2013 ident: 98646_CR34 publication-title: Nature doi: 10.1038/nature12439 – volume: 40 start-page: e53 issue: 7 year: 2012 ident: 98646_CR18 publication-title: Nucleic Acids Res. doi: 10.1093/nar/gkr1257 – volume: 519 start-page: 223 issue: 7542 year: 2015 ident: 98646_CR23 publication-title: Nature doi: 10.1038/nature14135 – volume: 97 start-page: 343 issue: 2 year: 2015 ident: 98646_CR36 publication-title: Am. J. Hum. Genet. doi: 10.1016/j.ajhg.2015.07.004 – ident: 98646_CR16 – volume: 108 start-page: 115 issue: 1 year: 2021 ident: 98646_CR40 publication-title: Am. J. Hum. Genet. doi: 10.1016/j.ajhg.2020.11.015 – volume: 54 start-page: 1 year: 2020 ident: 98646_CR30 publication-title: Annu. Rev. Genet. doi: 10.1146/annurev-genet-112618-043617 – volume: 19 start-page: 315 issue: 6 year: 2016 ident: 98646_CR4 publication-title: Public Health Genom. doi: 10.1159/000450991 – volume: 586 start-page: 757 issue: 7831 year: 2020 ident: 98646_CR24 publication-title: Nature doi: 10.1038/s41586-020-2832-5 – volume: 369 start-page: 1502 year: 2013 ident: 98646_CR6 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1306555 – volume: 100 start-page: 14 issue: 1 year: 2021 ident: 98646_CR5 publication-title: Clin. Genet. doi: 10.1111/cge.13946 – year: 2021 ident: 98646_CR25 publication-title: Clin. Genet. doi: 10.1111/cge.14006 – volume: 43 start-page: 860 issue: 4 year: 2013 ident: 98646_CR21 publication-title: J. Autism Dev. Disord. doi: 10.1007/s10803-012-1627-4 – volume: 98 start-page: 477 issue: 5 year: 2020 ident: 98646_CR33 publication-title: Clin. Genet. doi: 10.1111/cge.13823 – volume: 101 start-page: 664 issue: 5 year: 2017 ident: 98646_CR27 publication-title: Am. J. Hum. Genet. doi: 10.1016/j.ajhg.2017.09.008 – volume: 43 start-page: 491 issue: 5 year: 2011 ident: 98646_CR17 publication-title: Nat. Genet. doi: 10.1038/ng.806 – volume-title: WPPSI-III: Technical and Interpretative Manual year: 2002 ident: 98646_CR14 – volume-title: Wechsler Intelligence Scale for Children-Fifth Edition (WISC-V) year: 2014 ident: 98646_CR15 – volume: 50 start-page: 1048 issue: 7 year: 2018 ident: 98646_CR35 publication-title: Nat. Genet. doi: 10.1038/s41588-018-0143-7 – volume: 36 start-page: 928 issue: 10 year: 2015 ident: 98646_CR41 publication-title: Hum. Mutat. doi: 10.1002/humu.22844 – volume-title: The Social Communication Questionnaire—Manual year: 2003 ident: 98646_CR20 – volume: 10 start-page: 3043 issue: 1 year: 2019 ident: 98646_CR29 publication-title: Nat. Commun. doi: 10.1038/s41467-019-11039-6 – volume: 143 start-page: 1099 issue: 4 year: 2020 ident: 98646_CR2 publication-title: Brain doi: 10.1093/brain/awaa051 – volume: 394 start-page: 533 issue: 10197 year: 2019 ident: 98646_CR10 publication-title: Lancet doi: 10.1016/S0140-6736(19)31274-7 – volume: 385 start-page: 1305 issue: 9975 year: 2015 ident: 98646_CR11 publication-title: Lancet doi: 10.1016/S0140-6736(14)61705-0 |
| SSID | ssj0000529419 |
| Score | 2.435246 |
| Snippet | Exome sequencing (ES) is an important diagnostic tool for individuals with neurodevelopmental disorders (NDD) and/or multiple congenital anomalies (MCA).... Abstract Exome sequencing (ES) is an important diagnostic tool for individuals with neurodevelopmental disorders (NDD) and/or multiple congenital anomalies... |
| SourceID | doaj pubmedcentral proquest pubmed crossref springer |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 19099 |
| SubjectTerms | 631/208/1516 692/4017 692/617/375/366 Abnormalities, Multiple - diagnosis Abnormalities, Multiple - economics Abnormalities, Multiple - genetics Adolescent Adult Autism Child Child, Preschool Coexistence Congenital defects Congenital diseases Cost-Benefit Analysis Epilepsy Feasibility Studies Female Financing, Government Genetic Counseling - economics Genetic Counseling - methods Genetic Counseling - statistics & numerical data Genetic Testing - economics Genetic Testing - methods Genetic Testing - statistics & numerical data Humanities and Social Sciences Humans Infant Infant, Newborn Intellectual disabilities Israel Magnetic resonance imaging Male Maternal Age Microencephaly multidisciplinary Neurodevelopmental disorders Neurodevelopmental Disorders - diagnosis Neurodevelopmental Disorders - economics Neurodevelopmental Disorders - genetics Neuroimaging Paternal Age Pregnancy Premature birth Prenatal Diagnosis - economics Prenatal Diagnosis - methods Program Evaluation Retrospective Studies Science Science (multidisciplinary) Tertiary Care Centers - economics Tertiary Care Centers - statistics & numerical data Whole Exome Sequencing - economics Whole Exome Sequencing - statistics & numerical data Young Adult |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals (WRLC) dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYlUOilNH06L1TorTWRV5IlHZPSEArNKYHchF6mhY23ZDeE_Ib86cxItpNtm_bS62rWaDWfrG9WM98Q8kG0TgUju5qFFluYeYZJAL52RsdGhOhFLgr7dtIen4mv5_L8QasvzAkr8sBl4faT4tz7FqAXogg-uBhYVNo1jVeOh4hvX2bYg2CqqHrPjGjMUCXDuN5fwkmF1WSYkaBb0dbXaydRFuz_E8v8PVnylxvTfBAdvSDPBwZJD8rMN8mT1L8kT0tPyZtX5PaAYvg_TxQflS5pmsSMKf7pSouw9fyGdlg_FulYGwmGi4tEh9xqeAQFPkuz3mW8zywCuzgIdi4pjI8JiRTiasAitiChrl9cAL1Py9fk7OjL6efjeui4UAdgbqs6hqADkAAlfds0SZoY-EwBK_PGcZ2YlJ2MYKI7cEgIhrvYQYTSGaFawYTnb8hGv-jTO0KNjKyJQHA6n0XZjITYiUVmkgMsCF2RZlx9GwY5cuyKMbf5WpxrWzxmwWM2e8xeV-Tj9J2fRYzjr9aH6NTJEoW08wcALzvAy_4LXhXZGSFhh929tBikKcwmgl_xfhqGfYmXLa5Pi6tsowTYSbB5WxA0zYQLqeHlySui1rC1NtX1kf7H96z9DWQCOKKoyKcRhffTenwptv7HUmyTZzPcPnglp3bIxuryKu0CI1v5vbz57gDOGjcS priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Complete (ProQuest Database) dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagCIkL4k2gICNxg6hxbcf2CRVEVSHBiUp7s_wKIG2TsrtV1d_An2bGcbJaHr2uZyMnM2N_nhl_Q8hr0ToVjOzqJrTYwsw3WATga2d0ZCJEL_KlsM9f2pNT8WkhFyXgti5lldOamBfqOASMkR8gMFZYwaHfnf-ssWsUZldLC42b5BYDJIKtG9RCzTEWzGIJZspdmYbrgzXsV3inDOsSdCva-nJnP8q0_f_Cmn-XTP6RN83b0fE9crfgSHo0Kv4-uZH6B-T22Fny6iH5dUQxCLBMFB-VVjTNlMYUQ690pLdeXtEOb5FFOt2QBMHhLNFSYQ2PoIBqaWa9jNv6IpCLhbZzTWF8KkukcLoGi8RGJNT1wxmA_LR-RE6PP379cFKXvgt1APy2qWMIOgAUUNK3jCVpYuCHCrCZN47r1EjZyQgiums5C8FwFzs4p3RGqFY0wvPHZK8f-vSUUCNjwyLAnM5najYj4QTVxMYkBxYhdEXY9PVtKKTk2BtjaXNynGs7asyCxmzWmL2syJv5P-cjJce10u9RqbMk0mnnH4bVN1u80ybFuffwNtjKKfjgYmii0o4xrxwPsSL7k0nY4uNru7XIiryah8E7MeXi-jRcZBklQE6CzJPRguaZcCE1LKG8ImrHtnamujvS__ieGcABUgBSFBV5O1nhdlr__xTPrn-L5-TOIToGptzUPtnbrC7SC0BcG_8yu9VvBPss0A priority: 102 providerName: ProQuest – databaseName: Springer Nature HAS Fully OA dbid: AAJSJ link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELbKVkhcEG_SFmQkbhCRrO3YPi6IqloJLlCpN8uvANI2qXa3qvob-NPMOE6qhYLENR5bTjy2v8nMfEPIa95Y6bVoy8o3WMLMVRgE4EqrVai5D46npLBPn5uTU748E2d7ZD7mwqSg_URpmY7pMTrs3QYuGkwGw4AC1fCmvLpD9pWE43dG9heL5Zfl9GcFfVe81jlDpmLqls47t1Ai678NYf4ZKPmbtzRdQscPyP2MHulimO9Dshe7R-TuUE_y-jH5uaBo-q8ixaHimsaJyJjiD1c6kFqvrmmLuWOBjnmRINifR5rjqmEICliWJq7LcBNVBHIhk3VuKLSPwYgUbGrQQyw_Qm3XnwO0j5sn5PT449cPJ2WutlB6QG3bMnivPAAAKVxT11Ho4NlcAiJz2jIVKyFaEUBEtQ2rvdfMhhask1Zz2fCKO_aUzLq-i88J1SJUdQBw07pEyKYF2E1VqHS0oAdcFaQev77xmYocK2KsTHKJM2WGFTOwYiatmLkqyJupz8VAxPFP6fe4qJMkkminB_36m8lKZaJkzDl4Gyzg5J23wVdBKlvXTlrmQ0GORpUweWdvDBpoEiOJ4C1eTc2wJ9HRYrvYXyYZyUFOgMyzQYOmmTAuFBycrCByR7d2prrb0v34nni_AUgAPuQFeTtq4c20_v4pDv5P_JDcm-NGQcebPCKz7foyvgDctXUv80b7BWaSLI8 priority: 102 providerName: Springer Nature |
| Title | A single center experience with publicly funded clinical exome sequencing for neurodevelopmental disorders or multiple congenital anomalies |
| URI | https://link.springer.com/article/10.1038/s41598-021-98646-w https://www.ncbi.nlm.nih.gov/pubmed/34580403 https://www.proquest.com/docview/2576737608 https://www.proquest.com/docview/2577457658 https://pubmed.ncbi.nlm.nih.gov/PMC8476634 https://doaj.org/article/e733bb6318cd4cbcadc0d78a11b7a3cd |
| Volume | 11 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Zb9QwEB71EKgviJuUsjISbxBI1nYcPyC0XbWqVqJCwEr7ZsVHAGmb0N2tyv4G_jRj56gWtjxFiieRjxn5s2fmG4BXLCuEkbyME5P5EmY68UEAOi5kblNmrGYhKezjeXY2ZZMZn-1AV-6oncDl1qOdryc1Xczf_rpcf0CDf9-kjOfvlrgJ-UQxH2yQZyyLr3dhP_iLfChfC_cbru-hZKlsc2e2f3oAdynjOeo23diqAqP_Nhj6bzTlXy7VsFOd3od7LcQko0YnHsCOqx7Cnabo5PoR_B4Rfz8wd8T_yi2I69mOib-VJQ3z9XxNSp9gZkmXPImC9YUjbfA1_oIg4CWBENPehB6hnG0ZPZcE27uIRYIHb1RWX6OEFFV9gfjfLR_D9PTk6_gsbksyxAah3Sq2xuQGUYLgOktTx6U1dCgQtmlZ0NwlnJfcokheZjQ1RtLClniEKSUTGUuYpk9gr6or9wyI5DZJLSKgUgfWNsnxcJXYRLoClYXlEaTd7CvT8pX7shlzFfzmNFfN4ilcPBUWT11H8Lr_5mfD1vFf6WO_qL2kZ9oOL-rFN9UarnKCUq1xNL7Kk9GmsCaxIi_SVIuCGhvBUacSqtNe5U9xwocb4She9s1ouN4bU1SuvgoygqEcR5mnjQb1Pek0MAKxoVsbXd1sqX58D-TgiDYQRLII3nRaeNOt26fi8NYuPIeDoTcP74gTR7C3Wly5F4jDVnoAu2ImBrA_Gk2-TPB5fHL-6TO-HWfjQbjbGATz-wOPjDXn |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELbKVgguiDeBAkaCE0RN1nYehwq10GpL2xVCrdRb6lcAaZuUzVar_Q38J34bM46T1fLordd4YjmZ8fjzPAl5zROZ6lyUYaQTbGGmIgwCUKHMMxNzbRR3SWFH42R0wj-ditM18qvLhcGwyk4nOkVtao028k0ExilGcGTvL36E2DUKvatdCw3pWyuYLVdizCd2HNjFHK5wzdb-R-D3m-Fwb_f4wyj0XQZCDWhlFhqtMw0HXypUEsdW5EazYQpIROWSZTYSohQGSLIyYbHWOZOmBFRe5jxNeMQVg3lvkHWOBpQBWd_ZHX_-0lt50I_G49xn60Qs22zgxMSsNoyMyBKehPOVE9E1DvgX2v07aPMPz607EPfukjseydLtVvTukTVb3Sc3296Wiwfk5zZFM8TEUpzKTqntiypTNP7StsD2ZEFLzGMztMvRBML63FIf4w1TUMDV1NXdNMsIJ6AzvnBoQ2G8C4ykcL-HPYGtUKis6nO4ZtjmITm5Fp48IoOqruwTQnNhotgA0CqVKw6XC7jDRSbKrQSZ5FlA4u7vF9qXRcfuHJPCuedZVrQcK4BjheNYMQ_I2_6di7YoyJXUO8jUnhILersH9fRr4fVDYVPGlIKvwWZSWmlpdGTSTMaxSiXTJiAbnUgUXss0xXJPBORVPwz6AZ0-srL1paNJOdAJoHncSlC_EsZFBkqcBSRdka2Vpa6OVN-_uRrkAGoAq_KAvOukcLms__-Kp1d_xUtya3R8dFgc7o8PnpHbQ9wk6ABMN8hgNr20zwH_zdQLv8koObvuff0b8oVvxg |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Jb9QwFLZKKxAXxE6ggJHgBNEkYzt2DhVqaUcthVGFqNRbiJcA0jQpM61G8xv4Z_wq3nOcjIalt17jF8vJW_zZbyPkJc9KaXJRxYnJsIWZTjAIQMdlrmzKjdXcJ4V9HGf7x_z9iThZI7-6XBgMq-xsojfUtjF4Rz5AYCwxgkMNqhAWcbQ7env2I8YOUuhp7dpplKHNgt3y5cZCksehW8zhODfbOtgF3r8aDkd7n9_tx6HjQGwAuZzH1hhlYBOUQmdp6kRuDRtKQCU6L5lyiRCVsECiqoylxuSstBUg9CrnMuMJ1wzmvUY2JOz6cBDc2NkbH33qb3zQp8bTPGTuJEwNZrB7YoYbRkmojGfxfGV39E0E_oV8_w7g_MOL6zfH0W1yK6Baut2K4R2y5uq75Hrb53Jxj_zcpnglMXEUp3JT6voCyxQvgmlbbHuyoBXmtFna5WsCYXPqaIj3hikoYGzqa3DaZbQT0NlQRHRGYbwLkqRw1gf9wLYotKybUzhyuNl9cnwlPHlA1uumdo8IzYVNUgugq9K-UFwu4DyX2CR3JcgnVxFJu79fmFAiHTt1TArvqmeqaDlWAMcKz7FiHpHX_TtnbYGQS6l3kKk9JRb39g-a6dci2IrCSca0hq_BxlJGm9KaxEpVpqmWJTM2IpudSBTB4syKpX5E5EU_DLYCHUBl7ZoLTyM50AmgedhKUL8SxoUCg84iIldka2WpqyP192--HjkAHMCtPCJvOilcLuv_v-Lx5V_xnNwA_S4-HIwPn5CbQ9QR9AXKTbJ-Pr1wTwEKnutnQcco-XLVav0bQLp0Cg |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+single+center+experience+with+publicly+funded+clinical+exome+sequencing+for+neurodevelopmental+disorders+or+multiple+congenital+anomalies&rft.jtitle=Scientific+reports&rft.au=Pode-Shakked%2C+Ben&rft.au=Barel%2C+Ortal&rft.au=Singer%2C+Amihood&rft.au=Regev%2C+Miriam&rft.date=2021-09-27&rft.eissn=2045-2322&rft.volume=11&rft.issue=1&rft.spage=19099&rft_id=info:doi/10.1038%2Fs41598-021-98646-w&rft_id=info%3Apmid%2F34580403&rft.externalDocID=34580403 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2045-2322&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2045-2322&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2045-2322&client=summon |